CN106146371A - 苯并异硒唑酮类化合物代谢物、其合成方法及其应用 - Google Patents
苯并异硒唑酮类化合物代谢物、其合成方法及其应用 Download PDFInfo
- Publication number
- CN106146371A CN106146371A CN201510200518.4A CN201510200518A CN106146371A CN 106146371 A CN106146371 A CN 106146371A CN 201510200518 A CN201510200518 A CN 201510200518A CN 106146371 A CN106146371 A CN 106146371A
- Authority
- CN
- China
- Prior art keywords
- compound
- carcinoma
- alkyl
- formula
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510200518.4A CN106146371B (zh) | 2015-04-23 | 2015-04-23 | 苯并异硒唑酮类化合物代谢物、其合成方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510200518.4A CN106146371B (zh) | 2015-04-23 | 2015-04-23 | 苯并异硒唑酮类化合物代谢物、其合成方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106146371A true CN106146371A (zh) | 2016-11-23 |
CN106146371B CN106146371B (zh) | 2018-05-15 |
Family
ID=57347187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510200518.4A Active CN106146371B (zh) | 2015-04-23 | 2015-04-23 | 苯并异硒唑酮类化合物代谢物、其合成方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106146371B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113527301A (zh) * | 2020-04-13 | 2021-10-22 | 凯熙医药(武汉)股份有限公司 | 含四嗪取代基的芳并异硒唑类化合物及其合成方法和应用 |
WO2021223780A2 (zh) | 2020-05-06 | 2021-11-11 | 上海元熙医药科技有限公司 | 苯并异硒唑衍生物用于抗冠状病毒及控制冠状病毒相关的间质性肺疾病(ild)的用途 |
CN113527301B (zh) * | 2020-04-13 | 2024-05-17 | 凯熙医药(武汉)股份有限公司 | 含四嗪取代基的芳并异硒唑类化合物及其合成方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1594299A (zh) * | 2003-09-10 | 2005-03-16 | 北京大学药学院 | 双苯并异唑酮类化合物及其合成和应用 |
CN1990475A (zh) * | 2005-12-29 | 2007-07-04 | 曾慧慧 | 取代苯并异硒唑酮类化合物及其用途 |
CN101781283A (zh) * | 2009-01-16 | 2010-07-21 | 曾慧慧 | 硫氧还蛋白还原酶抑制剂化合物及其制备方法和其应用 |
-
2015
- 2015-04-23 CN CN201510200518.4A patent/CN106146371B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1594299A (zh) * | 2003-09-10 | 2005-03-16 | 北京大学药学院 | 双苯并异唑酮类化合物及其合成和应用 |
CN1990475A (zh) * | 2005-12-29 | 2007-07-04 | 曾慧慧 | 取代苯并异硒唑酮类化合物及其用途 |
CN101781283A (zh) * | 2009-01-16 | 2010-07-21 | 曾慧慧 | 硫氧还蛋白还原酶抑制剂化合物及其制备方法和其应用 |
Non-Patent Citations (1)
Title |
---|
HE, JIE等: "nhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones Organoselenium compounds for cancer therapy", 《BIOORGANIC&MEDICINALCHEMISTRY》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113527301A (zh) * | 2020-04-13 | 2021-10-22 | 凯熙医药(武汉)股份有限公司 | 含四嗪取代基的芳并异硒唑类化合物及其合成方法和应用 |
CN113527301B (zh) * | 2020-04-13 | 2024-05-17 | 凯熙医药(武汉)股份有限公司 | 含四嗪取代基的芳并异硒唑类化合物及其合成方法和应用 |
WO2021223780A2 (zh) | 2020-05-06 | 2021-11-11 | 上海元熙医药科技有限公司 | 苯并异硒唑衍生物用于抗冠状病毒及控制冠状病毒相关的间质性肺疾病(ild)的用途 |
WO2021223780A3 (zh) * | 2020-05-06 | 2021-12-30 | 上海元熙医药科技有限公司 | 苯并异硒唑衍生物用于抗冠状病毒及控制冠状病毒相关的间质性肺疾病(ild)的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN106146371B (zh) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105153122B (zh) | [(吲哚-3-基)嘧啶-2-基]氨基苯基丙-2-烯酰胺衍生物及盐、制备方法、应用 | |
CN101808516B (zh) | 作为mek抑制剂的包括多晶型物的n-(芳氨基)磺酰胺衍生物和组合物、其使用方法和制备方法 | |
CN102351842B (zh) | 甲磺酸伊马替尼的f、g、h、i 和k晶形 | |
CN102030742A (zh) | 作为酪氨酸激酶抑制剂的4-(取代苯胺基)喹唑啉衍生物 | |
CN103906749B (zh) | 原小檗碱类生物碱衍生物及其抗溃疡性结肠炎的用途 | |
CN102731485A (zh) | 4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途 | |
CN102796124B (zh) | 双β‑咔啉碱类化合物、其制法和其药物组合物与用途 | |
HUE027664T2 (en) | Nalbuphine-based preparations and their use | |
EP3929182A1 (en) | Multi-target kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof | |
CN102971312A (zh) | 吡咯取代的2-二氢吲哚酮衍生物、其制备方法及用途 | |
CN102766103A (zh) | 2-硫代-4-胺基-1-萘酚衍生物、其制备方法和用途 | |
WO2016155578A1 (zh) | 达格列净的新晶型及其制备方法 | |
CN106977472A (zh) | 苯并异硒唑酮修饰亚硝脲类化合物合成及其应用 | |
CN109111426A (zh) | 一类稠合双环杂芳基或芳基化合物,及其用途 | |
CN110357795A (zh) | 一种双胍衍生物、药物组合物、制备方法和其在制备抗肿瘤药物中的应用 | |
CN102108079B (zh) | 作为酪氨酸激酶抑制剂的4-(取代苯胺基)喹唑啉衍生物 | |
CN101314584A (zh) | HGF/c-Met信号通道抑制剂及其制备方法和用途 | |
CN106146371A (zh) | 苯并异硒唑酮类化合物代谢物、其合成方法及其应用 | |
CN105566305A (zh) | 4-(取代苯胺基)喹唑啉衍生物二甲苯磺酸盐的多晶型物及其制备方法和用途 | |
CN107141284B (zh) | 黄连碱类衍生物、其制备方法、药物组合物及抗肿瘤用途 | |
CN102731488A (zh) | 苯并咪唑类衍生物、及其制法和药物组合物与用途 | |
CN106349257B (zh) | 3位哌嗪桥连接的双β-咔啉碱类化合物及其制药用途 | |
CN113444074B (zh) | 一种具有EGFR和Wnt双重抑制作用的化合物及其制备方法和应用 | |
CN103864764A (zh) | 吲唑取代的嘧啶胺衍生物、其制备方法和用途 | |
CN110167548A (zh) | 用于治疗胃肠息肉的组合物和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180412 Address after: 210000 room 402, source science and Technology Park, 73 North Central Road, Gulou District, Nanjing, Jiangsu. Applicant after: NANJING KAIXI MEDICAL TECHNOLOGY CO., LTD. Address before: 300457 Tianjin International Biological Research Institute, 220 Dongting Road, Tianjin Development Zone, Tanggu District, Tianjin Applicant before: Kay Pharmaceutical (Tianjin) Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191118 Address after: 430075 Optics Valley biological city, 666, new high road, Wuhan, Hubei B3-3-5 Patentee after: Kaixi Pharmaceutical (Wuhan) Co., Ltd. Address before: 210000 room 402, source science and Technology Park, 73 North Central Road, Gulou District, Nanjing, Jiangsu. Patentee before: NANJING KAIXI MEDICAL TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191129 Address after: 200000 Shanghai City, Pudong New Area Chinese (Shanghai) free trade zone fanchun Road No. 400 Building 1 layer 3 Patentee after: Shanghai Yuanxi Pharmaceutical Technology Co., Ltd Address before: 430075 Optics Valley biological city, 666, new high road, Wuhan, Hubei B3-3-5 Patentee before: Kaixi Pharmaceutical (Wuhan) Co., Ltd. |